Pasteurella multocida vaccine

Details Pasteurella multocida vaccine Pasteurella multocida vaccine

A - Human Necessities

61

K

167/135

A61K 39/102 (2006.01)

Patent

CA 1336956

Mutogenesis of the Clemson University (CU) vaccine strain of P. multocida with N-methyl-N-nitro-N-nitrosoguanidine resulted in temperature sensitive (TS) mutants which grew at 37°C but not 42°C. Two mutants, PM#1 and PM#3, were found to provide turkeys with a level of protection against challenge with a virulent serotype 3 P. multocida strain (P-1059) comparable to the protection provided by the CU strain. Intravenous (IV) inoculation of PM#1, PM#3, and CU was used to determine differences in virulence. PM#1 and PM#3 resulted in lower mortality and lameness than the CU strain. Histopathological evaluation of spleens at 24, 48, and 72 hours post IV inoculation demonstrated that the CU strain induced 2 times more splenic necrosis than either PM#1 or PM#3.

594513

Affiliated with

Also associated with

Rating

Pasteurella multocida vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pasteurella multocida vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pasteurella multocida vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1310732